Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Journal of Computer Assisted Tomography
|
November 13, 2004
Evaluation of the quantitative capability of a high-resolution positron emission tomography scanner for small animal imaging
Frederic H Fahey, H Donald Gage, Nancy Buchheimer, et al.
JCI Insight
|
July 21, 2017
Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model
Angelical S Martin, Dennis M Abraham, Kathleen A Hershberger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 15, 2012
Common data elements for clinical research in Friedreich's ataxia
David R Lynch, Massimo Pandolfo, Jorg B Schulz, et al.
International Journal of Molecular Sciences
|
August 10, 2024
A Barth Syndrome Patient-Derived <i>D75H</i> Point Mutation in <i>TAFAZZIN</i> Drives Progressive Cardiomyopathy in Mice
Paige L Snider, Elizabeth A Sierra Potchanant, Zejin Sun, et al.
Journal of the American Heart Association
|
March 20, 2026
Ex Vivo Effect of Apixaban on Hemostatic Biomarkers in Children With Heart Disease: A SAXOPHONE Trial Substudy
Ghada A Aborkhees, Amy J Barr, Kevin Dietrich, et al.
Clinical Pharmacology and Therapeutics
|
June 24, 2025
Characterization of Apixaban Pharmacokinetics/Pharmacodynamics and Dose Assessment in Pediatric Patients with Congenital or Acquired Heart Disease
Antoinette Ajavon-Hartmann, Praneeth Jarugula, Hyunmoon Back, et al.
American Heart Journal
|
June 5, 2017
Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation
David J Goldberg, Victor Zak, Bryan H Goldstein, et al.
American Heart Journal
|
June 19, 2018
Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial
David J Goldberg, Victor Zak, Bryan H Goldstein, et al.
Journal of the American Heart Association
|
March 26, 2025
Methylated Arginine Metabolites as Biomarkers for Clinical Status and Response to Type 5 Phosphodiesterase Inhibition in Patients With Fontan Circulation
Ari Cedars, Cedric Manlhiot, Bhargava Kumar Chinni, et al.
Journal of the American College of Cardiology
|
December 6, 2023
Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease
R Mark Payne, Kristin M Burns, Andrew C Glatz, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Journal of Computer Assisted Tomography
|
November 13, 2004
Evaluation of the quantitative capability of a high-resolution positron emission tomography scanner for small animal imaging
Frederic H Fahey, H Donald Gage, Nancy Buchheimer, et al.
JCI Insight
|
July 21, 2017
Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model
Angelical S Martin, Dennis M Abraham, Kathleen A Hershberger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 15, 2012
Common data elements for clinical research in Friedreich's ataxia
David R Lynch, Massimo Pandolfo, Jorg B Schulz, et al.
International Journal of Molecular Sciences
|
August 10, 2024
A Barth Syndrome Patient-Derived <i>D75H</i> Point Mutation in <i>TAFAZZIN</i> Drives Progressive Cardiomyopathy in Mice
Paige L Snider, Elizabeth A Sierra Potchanant, Zejin Sun, et al.
Journal of the American Heart Association
|
March 20, 2026
Ex Vivo Effect of Apixaban on Hemostatic Biomarkers in Children With Heart Disease: A SAXOPHONE Trial Substudy
Ghada A Aborkhees, Amy J Barr, Kevin Dietrich, et al.
Clinical Pharmacology and Therapeutics
|
June 24, 2025
Characterization of Apixaban Pharmacokinetics/Pharmacodynamics and Dose Assessment in Pediatric Patients with Congenital or Acquired Heart Disease
Antoinette Ajavon-Hartmann, Praneeth Jarugula, Hyunmoon Back, et al.
American Heart Journal
|
June 5, 2017
Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation
David J Goldberg, Victor Zak, Bryan H Goldstein, et al.
American Heart Journal
|
June 19, 2018
Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial
David J Goldberg, Victor Zak, Bryan H Goldstein, et al.
Journal of the American Heart Association
|
March 26, 2025
Methylated Arginine Metabolites as Biomarkers for Clinical Status and Response to Type 5 Phosphodiesterase Inhibition in Patients With Fontan Circulation
Ari Cedars, Cedric Manlhiot, Bhargava Kumar Chinni, et al.
Journal of the American College of Cardiology
|
December 6, 2023
Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease
R Mark Payne, Kristin M Burns, Andrew C Glatz, et al.
Page
of 7